Home ⟩ Insights

Insights

story

16 min read • February 21, 2025

This Week In Cannabis: The MedMen Saga, Multi-Million-Dollar Financings, Controversies In LatAm And More

1 min read • February 20, 2025

Aurora Cannabis Reveals Extended Pastille Offerings In Australia

4 min read • February 19, 2025

Colombia Considers Allowing Cannabis Imports: Experts Say It Makes No Sense

4 min read • February 18, 2025

Brittney Griner Cancels Cannabis Keynote After Finding Disturbing Hotel Room Message

2 min read • February 18, 2025

Costa Rica Greenlights Medical Cannabis Sales In Pharmacies: What’s Next?

4 min read • February 18, 2025

EXCLUSIVE: US Cannabis Jobs To Reach 800K By 2029 Despite 8% Salary Drop

3 min read • February 17, 2025

Spain’s Largest Cannabis B2B Event, ICBC, Returns To Barcelona: Info, Discounts and More

2 min read • February 17, 2025

Cannabis Stock Movers For February 17, 2025

5 min read • February 17, 2025

Argentinian Government To Roll Back Medical Cannabis Program—300K Patients At Risk, Experts Warn: Legal Battle Ahead?

7 min read • February 17, 2025

EXCLUSIVE: Ex-Rep. Kinzinger On GOP’s Internal War Over Drug Policy, Cannabis, Psychedelics – ‘Quite Likely Legal In 5-10 Years’

6 min read • February 16, 2025

Super Bowl Champ’s Fight for Cannabis: ‘Opioids Are Killing Athletes’

2 min read • February 15, 2025

Women Grow Foundation: New 501(c)(3) to Provide Advocacy and Resources for Cannabis Entrepreneurs

Latest Headlines

3 min read • April 30, 2026

Cannabis Earnings Show How Verano and SNDL Are Navigating Margin Pressure, Pricing, and Uneven Demand

3 min read • April 30, 2026

Medical Cannabis Operators Face New Federal Compliance Costs as Schedule III Shift Advances

2 min read • April 29, 2026

This Southern State Is Still an Untapped Cannabis Market As Lawmakers Revisit Medical Marijuana Policy

3 min read • April 29, 2026

Vext Science Cannabis Co. Boosts Cash Flow 256% YoY, Margins Grow in 2025 Ahead of Ohio Push

3 min read • April 29, 2026

New Lawsuit Claims CMS Medicare Cannabis Program Undermines FDA-Approved Drug Development

4 min read • April 28, 2026

Psychedelics Enter Public Markets, Optimi CEO Points to Supply Bottleneck

3 min read • April 28, 2026

This Cannabis Giant Plans Nevada Registration, Here’s What Shareholders And Investors Need To Know

2 min read • April 28, 2026

TerrAscend Extends Cash Flow Streak To 15 Quarters As Growth Returns, Shares Pop

4 min read • April 27, 2026

DEA Opens Medical Marijuana Dispensary Registration Portal April 29: What Operators Need To Know

4 min read • April 27, 2026

Federal Cannabis Policy Just Changed Forever, Here’s What Rescheduling Order Really Means And What To Expect

4 min read • April 27, 2026

EXCLUSIVE: Safe Harbor Launches First Cannabis‑Ready 401K Plan

min read • April 27, 2026

Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator

Browse By Channels

After-Hours Center

Analyst Ratings

Be Your Own Boss

Broad U.S. Equity ETFs

Earnings Misses

Emerging Market ETFs

Emerging Markets

Entrepreneurship

Federal Reserve

Financial Advisors

Intraday Update

Macro Economic Events

Macro Notification

Market-Moving Exclusives

Movers & Shakers

Personal Finance

Pre-Market Outlook

Small Cap Analysis

Success Stories

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.